In a vote of 16-2, a key Food and Drug Administration (FDA) panel rejected a plan to approve Pfizer booster shots. The Associated Press reports that the panel voiced frustration that Pfizer had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results